| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae64c775f32c43199adbb4389c2c9b3 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00 |
| filingDate |
1993-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_026f7aea2b2eb827ac64f65cc6d13436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_435008045f40f9bf977e5e8677425f5d |
| publicationDate |
1995-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H0769851-A |
| titleOfInvention |
Oral composition |
| abstract |
(57) [Summary] [Structure] An oral composition comprising one or more non-steroidal anti-inflammatory agents in combination with minocycline hydrochloride. [Effect] The composition for oral cavity of the present invention has an excellent inhibitory effect on alveolar bone resorption by endotoxin of periodontopathic bacteria, and is effective for prevention and treatment of periodontal disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6713463-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006206613-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005104913-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4653282-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6458777-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9945910-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001335477-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016084287-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4721630-B2 |
| priorityDate |
1993-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |